SEC Form 4 · accession 0001179022-19-000025
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin D Freeman
Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 11, 2019 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | P | 1,500 | $4.285 | A | 1,500 | I | By a limited liability company wholly-owned by Freeman Global Holdings, LLC |
| Common Stock | holding | — | — | — | 22,043 | D | ||
| Common Stock | holding | — | — | — | 16,000 | I | IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.